PHS
BLUE

PFM Health Sciences’s bluebird bio BLUE Stock Holding History

PFM Health Sciences’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,758
Closed -$632K – 70
2024
Q4 		$632K Buy
+75,758
New +$662K 0.04% 82
2024
Q2 		– Sell
-102,133
Closed -$2.61M – 83
2024
Q1 		$2.61M Hold
102,133
– – 0.12% 78
2023
Q4 		$2.82M Sell
102,133
-199,914
-66% -$12.2M 0.17% 59
2023
Q3 		$18.4M Sell
302,047
-62,209
-17% -$4.37M 0.87% 42
2023
Q2 		$24M Buy
364,256
+134,967
+59% +$9.87M 0.93% 43
2023
Q1 		$14.6M Buy
229,289
+217,046
+1,773% +$24.8M 0.64% 52
2022
Q4 		$1.69M Buy
+12,243
New +$1.72M 0.06% 79
2018
Q2 		– Sell
-9,908
Closed -$21.9M – 116
2018
Q1 		$21.9M Sell
9,908
-884
-8% -$2.25M 0.45% 68
2017
Q4 		$24.9M Buy
+10,792
New +$21.9M 0.59% 61
2016
Q1 		– Sell
-51,557
Closed -$42.9M – 83
2015
Q4 		$42.9M Buy
+51,557
New +$51.5M 1.3% 31
2015
Q3 		– Sell
-9,818
Closed -$21.4M – 80
2015
Q2 		$21.4M Sell
9,818
-5,602
-36% -$11.4M 0.54% 54
2015
Q1 		$24.1M Sell
15,420
-13,549
-47% -$17.9M 0.67% 52
2014
Q4 		$34.4M Buy
28,969
+25,580
+755% +$17.1M 0.8% 42
2014
Q3 		$1.57M Buy
+3,389
New +$1.56M 0.04% 61
2014
Q2 		– Sell
-22,468
Closed -$6.62M – 64
2014
Q1 		$6.62M Sell
22,468
-254
-1% -$77K 0.12% 64
2013
Q4 		$6.17M Buy
22,722
+7,444
+49% +$2.08M 0.12% 58
2013
Q3 		$5.33M Buy
+15,278
New +$5.67M 0.13% 65

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

PFM Health Sciences's BLUE Position: Q1 2025 in Review

PFM Health Sciences sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 75,758 shares — an estimated $632K sold.

PFM Health Sciences first reported a position in BLUE in Q3 2013 and held it in 17 quarters. The position peaked at $42.9M in Q4 2015. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • PFM Health Sciences reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • PFM Health Sciences sold 75,758 bluebird bio shares in Q1 2025, an estimated $632K.
  • PFM Health Sciences first reported a position in bluebird bio in Q3 2013 and held it in 17 quarters.
  • PFM Health Sciences's bluebird bio position peaked at $42.9M in Q4 2015.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on PFM Health Sciences's 13F filing for Q1 2025, filed 15 May 2025.